RxDoctor Payments Data

Edda Casanova

Child & Adolescent Psychiatry · Deland, FLNPI 1215922695

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $693 and has fallen 52.3% since, to $330 in 2025.

$2,385in general payments, 2019–2025

Across 146 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$436
  • Supernus Pharmaceuticals, Inc.$347
  • Ironshore Pharmaceuticals Inc.$269
  • Takeda Pharmaceuticals U.S.A., Inc.$199
  • Tris Pharma Inc$179
  • Sunovion Pharmaceuticals Inc.$176
  • plus $778 from 12 others

What the payments were for

  • Food & beverage$2,385100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,385 in reported general payments places this provider in the 75th percentile of 206 child & adolescent psychiatry providers in Florida.

See all child & adolescent psychiatry providers in Florida

Other child & adolescent psychiatry in Deland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →